About Bioline  All Journals  Testimonials  Membership  News

African Health Sciences
Makerere University Medical School
ISSN: 1680-6905
EISSN: 1680-6905
Vol. 19, No. 1, 2019, pp. 1638-1646
Bioline Code: hs19038
Full paper language: English
Document type: Research Article
Document available free of charge

African Health Sciences, Vol. 19, No. 1, 2019, pp. 1638-1646

 en The perceived barriers to insulin therapy among type 2 diabetic patients
Hussein, Amin; Mostafa, Arafa; Areej, Alnomi; Mona, Al-muteb; Shimaa, Alduaiji; Najd, Al-Gazlan & Futoon, Alnemari


Background: Problems may arise with insulin treatment, due to patients’ perspective towards it leading to refusal.
Objectives: To evaluate diabetic patients’ refusal towards insulin therapy, and to assess patients' perception and perceived barriers towards insulin.
Methods: A cross-sectionalstudy, where type 2 diabetics participated in the study during a period, February through March 2017. They were interviewed in person by a questionnaire including three sections; socio-demography, medical history and a health belief model, comprising barriers to use insulin. Five points Likert scale was used to measure patients’ perception and barriers towards insulin therapy.
Results: One fourth (24.4%) of the diabetic patients refused insulin. Among the controlled group, 34.4% refused insulin, while 21% refused insulin among the uncontrolled group. The study showed different barriers towards insulin therapy, including fear of injection, pain, insulin injection needs help from others, fear of hypoglycaemia and embarrassment.
Conclusion: Diabetics showed a negative attitude towards insulin therapy due to social and psychological factors. The results necessitate the development of a strategy to address problems related with a reluctance to initiate insulin and put a strategy to implement education and better interaction with diabetic team to the stigma from phobia from insulin use.

Cite as: Hussein A, Mostafa A, Areej A, Mona A, Shimaa A, Najd A, et al. The perceived barriers to insulin therapy among type 2 diabetic patients. Afri Health Sci. 2019;19(1). 1638-1646.

Barriers to insulin therapy; type 2 diabetic patients

© Copyright 2019 - Hussein et al.

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil